Using Alternating Tangential Flow in a 3000-L perfusion bioreactor, the company expects to reduce production time by up to 30% At its manufacturing site in Songdo, South Korea, Samsung BioLogics (SBL) ...
Samsung BioLogics has implemented new perfusion technology that would reduce production time by up to 30 percent for its clients, the contract drug manufacturer said Monday. The company said it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback